2017 The Redefining Early Stage Investments (RESI) San Francisco Conference,

Natasha Eldridge

Life Science Nation (LSN) accelerates the business of early stage life science via a sourcing platform. This platform enables executives to find firms that are a fit for their company profile. Professionals leverage LSN to generate a global target list (GTL) of qualified prospects, significantly enhancing marketing efficiency. At LSN we research and curate market intelligence on two industry sectors: The first is emerging biotech and medtech companies, which by their ephemeral nature are challenging to find and track. Second, LSN tracks ten categories of early stage life science investors and identifies who is filling the void left by venture capital. LSN has developed unique methodologies for tracking and staying up-to-date with both of these dynamic market segments.

The RESI Conference began in 2013 to present a real partnering conference where early stage fundraising life science companies can meet with investors and get funded.

RESI CONFERENCE SERIES              TOTAL ATTENDEES         INVESTORS             COMPANIES               MEETINGS

                         YEAR 2015                        1584                              549                             662                            2108

                         YEAR 2016                         2404                             1097                            941                           3743

Annual Rate of Growth                                  52%                            100%                          42%                           78%  
(2015 - 2016)

 RESI SAN FRANCISCO                     TOTAL ATTENDEES         INVESTORS             COMPANIES               MEETINGS

RESI SF
Rate of Growth (2015 - 2016)                     56%                                  116%                        47%                            53%      

We do expect the same rate of growth or better this year. This is truly a wonderful opportunity to be involved with a rising conference in the life science industry where strategic relationships get developed and fundraising companies get funded.